Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Gubatan

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
The American Journal of Gastroenterology|November 6, 2020
Are Proton Pump Inhibitors Contributing to SARS-COV-2 Infection?Branden Tarlow, John Gubatan, Muhammad Ali Khan, et al.
World Journal of Gastrointestinal Oncology|August 30, 2021
Immune checkpoint inhibitor-mediated colitis in gastrointestinal malignancies and inflammatory bowel diseaseAlexa R Weingarden, Samuel J S Rubin, John Gubatan
Biomarker Research|September 22, 2016
Hypercalcemia associated with isolated bone marrow sarcoidosis in a patient with underlying monoclonal gammopathy of undetermined significance: case report and review of literatureJohn Gubatan, Xiaohui Wang, Abner Louissaint, et al.
Trends in Pharmacological Sciences|March 12, 2022
Selective tyrosine kinase 2 inhibitors in inflammatory bowel diseaseOle Haagen Nielsen, Theresa Louise Boye, Deepavali Chakravarti, et al.
World Journal of Clinical Cases|March 23, 2022
Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancySamuel J S Rubin, Tatiana Balabanis, John Gubatan, et al.
Cancers|September 9, 2022
The Tumor Immune Microenvironment in Pancreatic Ductal Adenocarcinoma: Neither Hot nor ColdSamuel J S Rubin, Raoul S Sojwal, John Gubatan, et al.
Alimentary Pharmacology & Therapeutics|October 25, 2019
Systematic review with meta-analysis: association of vitamin D status with clinical outcomes in adult patients with inflammatory bowel diseaseJohn Gubatan, Naomi D Chou, Ole Haagen Nielsen, et al.
Gastroenterology|May 11, 2020
SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern CaliforniaJohn Gubatan, Steven Levitte, Tatiana Balabanis, et al.
Biomolecules|November 25, 2023
Kinase Signaling in Colitis-Associated Colon Cancer and Inflammatory Bowel DiseaseMichelle Temby, Theresa L Boye, Jacqueline Hoang, et al.
ACG Case Reports Journal|November 30, 2022
Subcutaneous Sweet Syndrome Successfully Treated With Ustekinumab in a Patient With Ulcerative ColitisKelly A Hu, Jeanne Shen, Kerri Rieger, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
The American Journal of Gastroenterology|November 6, 2020
Are Proton Pump Inhibitors Contributing to SARS-COV-2 Infection?Branden Tarlow, John Gubatan, Muhammad Ali Khan, et al.
World Journal of Gastrointestinal Oncology|August 30, 2021
Immune checkpoint inhibitor-mediated colitis in gastrointestinal malignancies and inflammatory bowel diseaseAlexa R Weingarden, Samuel J S Rubin, John Gubatan
Biomarker Research|September 22, 2016
Hypercalcemia associated with isolated bone marrow sarcoidosis in a patient with underlying monoclonal gammopathy of undetermined significance: case report and review of literatureJohn Gubatan, Xiaohui Wang, Abner Louissaint, et al.
Trends in Pharmacological Sciences|March 12, 2022
Selective tyrosine kinase 2 inhibitors in inflammatory bowel diseaseOle Haagen Nielsen, Theresa Louise Boye, Deepavali Chakravarti, et al.
World Journal of Clinical Cases|March 23, 2022
Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancySamuel J S Rubin, Tatiana Balabanis, John Gubatan, et al.
Cancers|September 9, 2022
The Tumor Immune Microenvironment in Pancreatic Ductal Adenocarcinoma: Neither Hot nor ColdSamuel J S Rubin, Raoul S Sojwal, John Gubatan, et al.
Alimentary Pharmacology & Therapeutics|October 25, 2019
Systematic review with meta-analysis: association of vitamin D status with clinical outcomes in adult patients with inflammatory bowel diseaseJohn Gubatan, Naomi D Chou, Ole Haagen Nielsen, et al.
Gastroenterology|May 11, 2020
SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern CaliforniaJohn Gubatan, Steven Levitte, Tatiana Balabanis, et al.
Biomolecules|November 25, 2023
Kinase Signaling in Colitis-Associated Colon Cancer and Inflammatory Bowel DiseaseMichelle Temby, Theresa L Boye, Jacqueline Hoang, et al.
ACG Case Reports Journal|November 30, 2022
Subcutaneous Sweet Syndrome Successfully Treated With Ustekinumab in a Patient With Ulcerative ColitisKelly A Hu, Jeanne Shen, Kerri Rieger, et al.
Pageof 6